tiprankstipranks
SureNano Science Ltd (TSE:SURE)
:SURE
Canadian Market

SureNano Science Ltd (SURE) AI Stock Analysis

1 Followers

Top Page

TSE:SURE

SureNano Science Ltd

(SURE)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
C$0.15
▼(-48.67% Downside)
Action:ReiteratedDate:04/09/26
The score is held down primarily by very weak financial performance (persistent losses, zero recent revenue, ongoing cash burn, and negative equity). Technicals add limited support due to the price sitting well below key moving averages despite near-neutral momentum readings. Valuation is also constrained by a negative P/E and no dividend yield data.
Positive Factors
Low Reported Leverage
The lack of reported debt reduces near-term interest and refinancing pressure, giving the company more optionality to execute a restructuring or seek covenant-free financing. Over 2-6 months this materially lowers immediate default risk versus highly leveraged peers.
Negative Factors
Persistent Losses
Consistent negative operating results erode capital and limit reinvestment capacity. Over a multi-month horizon, ongoing losses increase the likelihood of further equity dilution or emergency financing, constraining strategic options and long-term competitiveness.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Reported Leverage
The lack of reported debt reduces near-term interest and refinancing pressure, giving the company more optionality to execute a restructuring or seek covenant-free financing. Over 2-6 months this materially lowers immediate default risk versus highly leveraged peers.
Read all positive factors

SureNano Science Ltd (SURE) vs. iShares MSCI Canada ETF (EWC)

SureNano Science Ltd Business Overview & Revenue Model

Company Description
SureNano Science Ltd. operates as a nanotechnology supply company in Canada and Colorado, the United States. The company distributes SureNano surfactant, a ready-to-mix food-grade compound that provides the base for high performance hemp and canna...
How the Company Makes Money
null...

SureNano Science Ltd Financial Statement Overview

Summary
Financial profile is very weak: losses and negative EBIT/EBITDA persist, recent revenue is effectively zero (2023–2025), and operating/free cash flow are negative each year. While there is no reported debt, equity turned negative in 2024 and worsened in 2025 alongside shrinking assets, indicating balance-sheet stress and likely reliance on external funding.
Income Statement
9
Very Negative
Balance Sheet
14
Very Negative
Cash Flow
12
Very Negative
BreakdownTTMMar 2024Jun 2023Jun 2022Mar 2022Mar 2021
Income Statement
Total Revenue0.000.000.000.0018.00K36.00K
Gross Profit-1.88K-2.50K-2.50K-3.75K16.51K34.66K
EBITDA-407.27K-57.09K-277.39K-380.27K-1.12M-81.59K
Net Income-226.77K-59.59K-279.89K-384.02K-1.12M-82.51K
Balance Sheet
Total Assets1.20M54.27K153.11K317.61K686.44K966.81K
Cash, Cash Equivalents and Short-Term Investments1.17M23.49K134.80K276.99K667.09K929.01K
Total Debt0.000.000.000.000.000.00
Total Liabilities34.16K134.04K173.29K57.90K36.49K17.32K
Stockholders Equity1.17M-79.77K-20.18K259.71K649.95K949.49K
Cash Flow
Free Cash Flow-208.53K-161.31K-142.19K-403.63K-669.76K-102.99K
Operating Cash Flow-208.53K-161.31K-142.19K-383.63K-669.76K-102.99K
Investing Cash Flow0.000.000.00-6.47K0.000.00
Financing Cash Flow1.39M50.00K0.000.00407.85K1.03M

SureNano Science Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.30
Price Trends
50DMA
0.29
Negative
100DMA
0.26
Negative
200DMA
0.20
Negative
Market Momentum
MACD
-0.01
Positive
RSI
32.59
Neutral
STOCH
41.98
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:SURE, the sentiment is Negative. The current price of 0.3 is above the 20-day moving average (MA) of 0.28, above the 50-day MA of 0.29, and above the 200-day MA of 0.20, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 32.59 is Neutral, neither overbought nor oversold. The STOCH value of 41.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:SURE.

SureNano Science Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
C$3.16B22.3428.32%30.36%181.15%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
48
Neutral
C$921.41M-46.51-2.55%2.55%8.04%-195.66%
44
Neutral
C$256.96M-3.44-414.40%6.29%-3.71%
43
Neutral
C$6.44M-6.5491.27%
42
Neutral
C$12.21M-2.61-86.94%-15.84%-375.96%
42
Neutral
C$114.89M-10.77-50.81%56.03%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:SURE
SureNano Science Ltd
0.19
0.11
137.50%
TSE:CNO
California Nanotechnologies
0.26
-0.54
-67.72%
TSE:NANO
Nano One Materials
0.96
0.31
47.69%
TSE:VNP
5N Plus
35.47
29.76
521.19%
TSE:NEO
Neo Performance Materials Inc
22.15
13.12
145.18%
TSE:GMG
Graphene Manufacturing Group Ltd
2.06
1.42
221.88%

SureNano Science Ltd Corporate Events

Business Operations and StrategyExecutive/Board ChangesM&A Transactions
SureNano Buys GlucaPharm to Drive Next-Generation GLP-1 Drug Push
Positive
Feb 23, 2026
SureNano Science Ltd. has completed the acquisition of GlucaPharm Inc., gaining control of GEP44, a patented, second-generation GLP peptide that has shown significant weight-loss and blood-glucose benefits in preclinical studies with fewer gastroi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 09, 2026